Safety and Effect of SANGUINATE™ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH)

Clinical trial NCT02323685 · COMPLETED

Trial details

NCT number: NCT02323685
Sponsor: Prolong Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cerebral Ischemia

Start date: 2014-12-01
Primary completion: 2016-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.